(ACAS) Announces Plans to Split into Three Companies

BETHESDA, Md., Nov. 5, 2014 — American Capital, Ltd. (Nasdaq: ACAS) (“American Capital” or the “Company”) announced today that its Board of Directors has unanimously approved a plan to split the Company’s businesses by transferring most of the Corporation’s investment assets to two newly established business development companies (“BDCs”) and having American Capital continue primarily in the asset management business.  It is contemplated that American Capital will spin off the new BDCs to its shareholders, resulting in three, publicly-traded companies.

The two new BDCs are anticipated to qualify and elect to be taxed as regulated investment companies with the objective of paying market rate dividends.  The two planned BDCs are as follows:

• American Capital Growth and Income, Ltd., whose assets will consist primarily of securities issued by operating companies purchased through American Capital One Stop Buyouts, senior floating rate loans to private companies and CLO equity investments. Based on the Company’s current asset composition, this business is at present allocated approximately $3 billion of equity.
• American Capital Income, Ltd., whose assets will consist primarily of second lien and mezzanine loans to middle market companies of the type currently originated by American Capital’s Sponsor Finance business. Based on the Company’s current asset composition, this business is at present allocated approximately $1 billion of equity.

Each of the new BDCs will enter into management agreements to be managed by American Capital, where all employees would reside.  Those management agreements are expected to be on terms consistent with current market practices.  As part of the transaction, American Capital will consolidate its operations and remaining assets with American Capital Asset Management, LLC, its existing wholly-owned asset management portfolio company, and will discontinue being an investment company.  Based on the company’s current asset composition, this business is at present allocated approximately $1 billion of equity.

“We believe that this transaction should be of significant benefit to our shareholders,” said Malon Wilkus, Chairman and CEO of American Capital.  “Separating our robust asset management business from our investment assets and allocating our investments between two distinct investment strategies will better tailor our businesses to the investment interests of our shareholders.  These steps will offer greater transparency, allow investors to understand better the underlying value of our businesses, provide for differing dividend policies and should make us more competitive in the markets in which we operate.”

American Capital also announced that due to changes in the composition of its investment portfolio and market conditions, it has undertaken various cost saving initiatives, which are expected to result in approximately $25 million of reduced costs annually, beginning in early 2015.  Also, the Company will implement a program under which portfolio companies in which it or its managed funds have invested will reimburse the Company for certain services the Company provides to those portfolio companies.  Based on current service levels and consistent with market practices and contractual understandings, this program is expected to provide for reimbursements at a $21 million annual rate by the end of 2015.  In addition, at least $25 million of the Company’s current annual SG&A is for the benefit of funds that will be under management following the split, and the Company expects that such amount will be reimbursable under management fee agreements consistent with market practices.

“Our cost reductions, which primarily result from the elimination of staff positions, reflect changes in the composition of our assets and market conditions and should be of continuing benefit to our shareholders,” said John Erickson, President, Structured Finance, and Chief Financial Officer of American Capital.  “Similarly, we expect the reimbursement for services to portfolio companies and the funds that we manage to benefit American Capital shareholders as we appropriately allocate costs among various companies.  To the extent that we are not able to achieve the expected level of reimbursements, we intend to reduce American Capital’s costs.”

The Company added that it will seek to accomplish the spin off of American Capital Growth and Income by issuing a tax free dividend to its shareholders and that the spin off of American Capital Income is expected to be treated as a taxable dividend to its shareholders.  American Capital will continue to be a taxable corporation and will retain any net operating losses that exist at the time of the spin offs. The transaction is subject to certain conditions including the approval of American Capital shareholders who, among other matters, must approve American Capital’s de-election to be regulated as a BDC under the Investment Company Act of 1940, as amended.

Other conditions to completion of the transaction include final approval by the American Capital Board of Directors, receipt of a tax opinion from our tax advisers, the filing of registration statements with the U.S. Securities and Exchange Commission (“SEC”) and their effectiveness, the holding of a special meeting of shareholders and the filing with and review of a proxy statement for that meeting by the SEC staff, the refinancing of American Capital’s indebtedness and the establishment of credit facilities for the new BDCs.  The transaction may also need regulatory relief from the SEC.  American Capital expects to make necessary filings with the SEC as soon as practicable.  There can be no assurances regarding the timing of the transaction, whether the transaction will be completed or the tax treatment of the transaction.

ABOUT AMERICAN CAPITAL
American Capital, Ltd. (Nasdaq: ACAS) is a publicly traded private equity firm and global asset manager.  American Capital, both directly and through its asset management business, originates, underwrites and manages investments in middle market private equity, leveraged finance, real estate, energy & infrastructure and structured products.  American Capital manages $21 billion of assets, including assets on its balance sheet and fee earning assets under management by affiliated managers, with $80 billion of total assets under management (including levered assets). Through an affiliate, American Capital manages publicly traded American Capital Agency Corp. (Nasdaq: AGNC), American Capital Mortgage Investment Corp. (Nasdaq: MTGE) and American Capital Senior Floating, Ltd. (Nasdaq: ACSF) with approximately $11 billion in total net book value.  From its eight offices in the U.S. and Europe, American Capital and its affiliate, European Capital, will consider investment opportunities from $10 million to $750 million. For further information, please refer to www.AmericanCapital.com.

FORWARD LOOKING STATEMENTS AND ADDITIONAL INFORMATION
This press release contains forward-looking information and statements.  Forward-looking statements give our current expectations and projections relating to the Company’s financial condition, results of operations, plans, objectives, future performance and business.  You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts.  These statements may include words such as “anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “believe,” “confident,” “may,” “should,” “can have,” “likely,” “future” and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events.  Forward looking statements are not guarantees of performance or results, and involve known and unknown risks, uncertainties (some of which are beyond the Company’s control), assumptions and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements.  Should one or more of these risks or uncertainties materialize, the Company’s actual results may vary in material respects from those projected in any forward-looking statements.  A detailed discussion of these and other factors that may affect future results is contained in our filings with the U.S. Securities and Exchange Commission.  Any forward-looking statement made by the Company in this press release speaks only as of the date on which it is made.  The Company undertakes no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

This press release does not constitute the solicitation of any vote, proxy or approval from any investor or security holder.  No such solicitation will be made except pursuant to a proxy statement filed with the SEC.  This press release also does not constitute an offer to sell or buy any securities. 

Contact:
Investor Relations – (301) 951-5917

(MCF) Plan to Repurchase Shares under Existing Share Repurchase Program

Contango Oil & Gas Company (NYSE MKT: MCF) announced today that its Board of Directors has decided to resume the repurchase of its common shares under the Company’s 2011 Share Repurchase Program (the “Program”). The Board’s decision to resume the repurchase of shares is based on its belief that the current market price reflects a significant discount to the estimated inherent value of the Company’s stock and represents an excellent investment opportunity for its shareholders. Shares may be purchased through open market or privately negotiated purchases in accordance with the provisions of the Program, the Company’s insider trading policy, applicable securities laws, and other legal requirements. Repurchased shares of common stock will become authorized but unissued shares, and may be reissued in the future for general corporate and other purposes. The Program was approved and originally implemented in September 2011, with a total of $50.0 million authorized for the repurchase of shares. As of the date of this release, $39.2 million remains available for share repurchases under the Program.

The Company and the members of its bank group have recently amended provisions of the Company’s credit agreement to provide the authority, subject to certain limitations, to repurchase shares up to the remaining availability under the Program. Shares will be repurchased with internally generated cash flow and the utilization of borrowings under the Company’s revolving credit facility.

Allan D. Keel, President and Chief Executive Officer of the Company, commented: “The recent softness in the stock market for upstream equity securities, including Contango’s, has created an opportunity for us to prudently acquire a portion of our outstanding shares at a very attractive valuation. We believe our stock to be undervalued by the market, so we feel it is an excellent opportunity to invest in our own shares while continuing to maintain a conservative balance sheet.”

Contango Oil & Gas Company is a Houston, Texas based, independent energy company engaged in the exploration, development, exploitation, production and acquisition of natural gas and crude oil properties offshore in the shallow waters of the Gulf of Mexico and in the onshore Gulf Coast regions of the United States and Rocky Mountains. Additional information is available on the Company’s website at http://www.contango.com.

This press release contains forward-looking statements regarding Contango that are intended to be covered by the safe harbor “forward-looking statements” provided by the Private Securities Litigation Reform Act of 1995, based on Contango’s current expectations and includes statements regarding acquisitions and divestitures, estimates of future production, future results of operations, quality and nature of the asset base, the assumptions upon which estimates are based and other expectations, beliefs, plans, objectives, assumptions, strategies or statements about future events or performance (often, but not always, using words such as “expects”, “projects”, “anticipates”, “plans”, “estimates”, “potential”, “possible”, “probable”, or “intends”, or stating that certain actions, events or results “may”, “will”, “should”, or “could” be taken, occur or be achieved). Statements concerning oil and gas reserves also may be deemed to be forward looking statements in that they reflect estimates based on certain assumptions that the resources involved can be economically exploited. Forward-looking statements are based on current expectations, estimates and projections that involve a number of risks and uncertainties, which could cause actual results to differ materially from those, reflected in the statements. These risks include, but are not limited to: the risks of the oil and gas industry (for example, operational risks in exploring for, developing and producing crude oil and natural gas; risks and uncertainties involving geology of oil and gas deposits; the uncertainty of reserve estimates; the uncertainty of estimates and projections relating to future production, costs and expenses; potential delays or changes in plans with respect to exploration or development projects or capital expenditures; health, safety and environmental risks and risks related to weather such as hurricanes and other natural disasters); uncertainties as to the availability and cost of financing; fluctuations in oil and gas prices; risks associated with derivative positions; inability to realize expected value from acquisitions, inability of our management team to execute its plans to meet its goals, shortages of drilling equipment, oil field personnel and services, unavailability of gathering systems, pipelines and processing facilities and the possibility that government policies may change or governmental approvals may be delayed or withheld. Additional information on these and other factors which could affect Contango’s operations or financial results are included in Contango’s other reports on file with the Securities and Exchange Commission. Investors are cautioned that any forward-looking statements are not guarantees of future performance and actual results or developments may differ materially from the projections in the forward-looking statements. Forward-looking statements are based on the estimates and opinions of management at the time the statements are made. Contango does not assume any obligation to update forward-looking statements should circumstances or management’s estimates or opinions change. Initial production rates are subject to decline over time and should not be regarded as reflective of sustained production levels.

(UQM) Signs Strategic Long-Term Agreement to Supply Electric Power Systems

UQM Technologies Inc. (NYSE MKT: UQM) has signed a long-term supply agreement to provide electric power systems for industrial and commercial applications to a pioneering energy management company. UQM PowerPhase^® electric motors and controllers will be incorporated with this partner’s proprietary technology to create new solutions to address the needs of its global customer base in a wide range of large industrial and commercial facilities. Pilot shipments are expected to begin in early 2015, followed by another purchase order for 500 units once certification is complete and follow-on customer orders are received. These production units are expected to start shipping in late calendar year 2015.

“We see this announcement as a significant milestone for UQM. The addition of this new high-volume market segment with different end customers expands our targeted market and complements our current core vehicle market,” said Eric R. Ridenour, President and Chief Executive Officer of UQM Technologies, Inc. “The proven high-efficiency, high-power output and robust design of our systems makes them ideally suited to energy management solutions such as this. We are excited to have been selected by this customer and to enter this new segment.”

About UQM

UQM Technologies is a developer and manufacturer of power-dense, high-efficiency electric motors, generators and power electronic controllers for the commercial truck, bus, automotive, marine, military and industrial markets. A major emphasis for UQM is developing propulsion systems for electric, hybrid electric, plug-in hybrid electric and fuel cell electric vehicles. UQM is TS 16949 certified and located in Longmont, Colorado.

This Release contains statements that constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. These statements appear in a number of places in this Release and include statements regarding our plans, beliefs or current expectations; including those plans, beliefs and expectations of our management with respect to, among other things, new product developments, future orders to be received from our customers, sales of products from inventory, future financial results, liquidity and the continued growth of the electric-powered vehicle industry. Important Risk Factors that could cause actual results to differ from those contained in the forward-looking statements are contained in our Form 10-K and Form 10-Qs, which are available through our website at www.uqm.com or at www.sec.gov.

(URZ) Permit Application for Third Powder River Basin Mining Unit Deemed ‘Complete’

(FNJN) Subsidiary Files New Patent Infringement Lawsuit Against Palo Alto Networks

NEW YORK, Nov. 5, 2014 — Finjan Holdings, Inc. (NASDAQ: FNJN), a technology company committed to advancing innovation through the licensing of its intellectual property (IP), today announced that its subsidiary, Finjan, Inc. (Finjan) has filed a patent infringement lawsuit against Palo Alto Networks, Inc. (NYSE: PANW) (Palo Alto Networks), alleging infringement of Finjan patents relating to endpoint, web, and network security technologies.

The Complaint (3:14-cv-04908, docket No. 1), filed November 4, 2014, in the U.S. District Court for the Northern District of California, alleges that Palo Alto Networks’ products and services infringe ten Finjan patents. In particular, Finjan is asserting infringement of U.S. Patent Nos. 6,804,780; 6,965,968; 7,058,822; 7,418,731; 7,613,918; 7,613,926; 7,647,633; 8,141,154; 8,225,408; and 8,677,494.

Finjan is seeking a jury trial; entry of judgment of infringement of certain claims of each of the asserted patents by Palo Alto Networks; preliminary and permanent injunction against Palo Alto Networks and its officers, among others, from infringing the asserted patents; damages of no less than $60 million to the extent proven at trial; enhanced damages, up to three times the amount of the damages, for willful disregard of our patent rights; and reasonable attorneys’ fees and costs.

“Finjan is committed to protecting the value of its patent portfolio for those who have respected our legitimate patent rights and have taken a patent license or invested in our business. We made numerous attempts for more than a year to have Palo Alto Networks join us in meaningful, good faith discussions to no avail,” stated Julie Mar-Spinola, Finjan’s VP of Legal Operations. “We provided Palo Alto Networks with exemplary detailed claim charts on several of the asserted patents, establishing how they each read on their products, and offered to provide additional claim charts under an NDA Standstill Agreement. Despite our best efforts, Palo Alto Networks chose to ignore the opportunity to have a business discussion and instead chose litigation.”

Finjan has also filed patent infringement lawsuits against Blue Coat, FireEye, Proofpoint, Sophos and Symantec relating to, collectively, more than 20 patents in the Finjan portfolio. Finjan will continue to provide timely updates of important events relating to these matters on an ongoing basis. The court dockets for the foregoing cases are publicly available on the Public Access to Court Electronic Records (PACER) website, http://www.pacer.gov, which is operated by the Administrative Office of the U.S. Courts.

Recognized internationally as a pioneer and leader in web and network security, Finjan’s decades-long investment in innovation is captured in its patent portfolio, centered around software and hardware technologies capable of proactively detecting previously unknown and emerging threats on a real-time, behavior-based basis. Finjan has successfully licensed its patents and technology to several major software and technology companies around the world.

ABOUT FINJAN HOLDINGS

Through our subsidiary, Finjan, Inc., we own a portfolio of patents, related to software that proactively detects malicious code and thereby protects end users from identity and data theft, spyware, malware, phishing, trojans and other online threats. Finjan’s mission is to invest in innovation and encourage the development of core intellectual property. Founded in 1997, Finjan developed and patented technology that is capable of detecting previously unknown and emerging threats on a real-time, behavior-based, basis, in contrast to signature-based methods of intercepting only known threats to computers, which were standard in the online security industry during the 1990’s. For more information about Finjan, please visit www.finjan.com.

Follow Finjan Holdings on LinkedIn at www.linkedin.com/company/finjan or on Twitter at www.twitter.com/FinjanHoldings or @FinjanHoldings.

Cautionary Note Regarding Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements regarding our expectations, intentions, beliefs, and projections about our future results, performance, prospects, and opportunities. These statements can be identified by the fact that they do not relate strictly to historical or current facts or by the use of words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “project,” “potential,” “should,” “will,” “will be,” “would,” the negative of these terms and similar expressions, but this is not an exclusive way of identifying such statements. Readers are cautioned that forward-looking statements are not guarantees of future performance. Our actual results, performance, and achievements may differ materially from those expressed in, or implied by, the forward-looking statements contained in this press release as a result of various risks, uncertainties and other factors. Important factors that could cause our actual results to differ materially from our expectations include, without limitation, our ability to execute our business plan, the outcome of pending or future enforcement actions, our ability to expand our technology portfolio, the enforceability of our patents, the continued use of our technology in the market, the development of a liquid trading market for our securities, regulatory developments, and other factors described under Item 1A, “Risk Factors,” as set forth in the Company’s Annual Report on form 10-K filed with the SEC on March 14, 2014, and any subsequent quarterly or current reports.

The Company will continue to file annual, quarterly, and current reports, proxy statements and other information with the SEC. Forward-looking statements speak only as of the dates specified in such filings or releases. Except as expressly required under federal securities laws and the rules and regulations of the Securities and Exchange Commission, we do not undertake any obligation to update any forward-looking statements to reflect events or circumstances arising after any such date, whether as a result of new information or future events or otherwise. You should not place undue reliance on the forward-looking statements included in this release or that may be made elsewhere from time to time by us, or on our behalf. All forward-looking statements attributable to us are expressly qualified by these cautionary statements.

Contact
Investor Relations | Friederike Edelmann | Finjan Holdings, Inc.
Telephone: (646) 350-4999 | Email: friederike@finjan.com

Media and Press Relations | Katie Hepler | MWW Group
Telephone: (212) 704-9727 | Email: khepler@mww.com

(BSFT) Verizon Selects BroadSoft to Enhance Fixed Mobile Convergence Business Services

(SCON) Preparing for Commercial Production of Conductus Superconducting Wire

– New Conductus production machine operational –

– Strong customer demand for Conductus continues to outpace supply –

AUSTIN, Texas, Nov. 4, 2014 — Superconductor Technologies Inc. (Nasdaq:SCON) (“STI”), a world leader in the development and production of high temperature superconducting (HTS) materials and associated technologies, reported its one kilometer RCE system (RCE-1000) completed final assembly, meets all required design specifications and is operational. Now STI is focused on software testing and process development as it prepares to scale production for the commercial launch of Conductus^® wire.

“With our RCE-1000, SDP and IBAD machines operational, we are positioned to produce Conductus wire on a commercial scale,” said Jeff Quiram, STI’s president and chief executive officer. “Previously, the limited capacity of our pilot equipment constrained our customers’ evaluation and qualification process. We are very excited we have the ability to increase Conductus supply, which will enable our customers to conclude testing in their electrical devices and initiate their production orders.”

“Our customer demand is increasing as the industry begins to focus on commercialization of superconducting products. We continue to strengthen relationships with existing customers as well as engage with new ones who initiated evaluation for the qualification of Conductus wire for use in their devices. During the third quarter of 2014, we shipped Conductus wire to four new and six existing customers. Of these ten customers, seven are in Stage 1 evaluation, including wire characterization and performance testing, and three are for Stage 2, involving significantly more rigorous testing to simulate devices for commercial deployment. The additional orders continue to outpace our supply, and the commercial RCE-1000 will alleviate this constraint as we ramp availability in late 2014 and beyond.”

Conductus® Superconducting Wire Manufacturing

To produce Conductus wire there are three key manufacturing processes:

(1)   Solution Deposition Planarization (SDP) to smooth commercial-grade stainless steel or hastelloy substrate;

(2)   Ion Beam Assisted Deposition (IBAD) to produce a template, allowing for the right surface conditions for the growth of superconducting material; and

(3)   The proprietary Reactive Co-evaporation Cyclic Deposition and Reaction (RCE-CDR) of superconducting materials onto the manufactured template.

About Superconductor Technologies Inc. (STI)

Superconductor Technologies Inc., headquartered in Austin, TX, has been a world leader in HTS materials since 1987, developing more than 100 patents as well as proprietary trade secrets and manufacturing expertise. For more than a decade, STI has been providing innovative interference elimination and network enhancement solutions to the commercial wireless industry. The company is currently leveraging its key enabling technologies, including RF filtering, HTS materials and cryogenics to develop energy efficient, cost-effective and high performance second generation (2G) HTS wire for existing and emerging power applications, to develop applications for advanced RF wireless solutions and innovative adaptive filtering, and for government R&D. Superconductor Technologies Inc.’s common stock is listed on the NASDAQ Capital Market under the ticker symbol “SCON.” For more information about STI, please visit http://www.suptech.com.

Safe Harbor Statement

Statements in this press release regarding our business that are not historical facts are “forward-looking statements” that involve risks and uncertainties. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors, which could cause actual results to differ materially from the forward-looking statements. These factors and uncertainties include, but are not limited to: the ability of our suppliers, who we do not control, to produce and deliver equipment on a timely basis; our ability to incorporate and fully assemble new equipment effectively and on time into our production processes; our ability to calibrate and use new equipment to produce wire in accordance with our timetable; our limited cash and a history of losses; the limited number of potential customers; the limited number of suppliers for some of our components and our HTS wire; there being no significant backlog from quarter to quarter; our market being characterized by rapidly advancing technology; overcoming technical challenges in attaining milestones to develop and manufacture commercial lengths of our HTS wire; customer acceptance of our HTS wire; fluctuations in product demand from quarter to quarter; the impact of competitive filter products, technologies and pricing; manufacturing capacity constraints and difficulties; our ability to raise sufficient capital to fund our operations (whether through registered direct offerings or otherwise), and the impact on our strategic wire initiative of any inability to raise such funds; the impact of any such financing activity on the level of our stock price, which may decline in connection with the sales under registered direct offerings or otherwise; the dilutive impact of any issuances of securities to raise capital; and local, regional, and national and international economic conditions and events and the impact they may have on us and our customers, such as the current worldwide recession.

Forward-looking statements can be affected by many other factors, including, those described in the “Business” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of STI’s Annual Report on Form 10-K for the year ended December 31, 2013 and in STI’s other public filings. These documents are available online at STI’s website, www.suptech.com, or through the SEC’s website, www.sec.gov. Forward-looking statements are based on information presently available to senior management, and STI has not assumed any duty to update any forward-looking statements.

CONTACT: Investor Relations Contact
         Cathy Mattison or Kirsten Chapman
         LHA
         +1-415-433-3777
         invest@suptech.com

(QUIK) Announces Production with Samsung NX1 Compact System Camera

(VSR) Awarded $5.1 Million Chemical Splash Protective Suit Framework Contract

SPRINGFIELD, Va., Nov. 4, 2014  — Versar, Inc. (NYSE MKT: VSR) announced today that its wholly-owned subsidiary, VersarPPS, will supply the United Kingdom’s Department for International Development (DFID) with chemical splash protective suits.  The contract is a single framework award valued at $5.1 million. VersarPPS will deliver the chemical splash protective suits over the next few months, and the contract is expected to be completed by the end of March 2015. These chemical splash protective suits will be distributed in support of the emergency response to the Ebola outbreak.

Tony Otten, CEO of Versar said, “We are proud to provide support to the Department for International Development. This award illustrates the valuable contributions of our emergency response manufacturing facility, VersarPPS.”

VERSAR, INC., headquartered in Springfield, Virginia, is a publicly-traded global project management company providing sustainable value oriented solutions to government and commercial clients in the construction management, environmental services, munitions response, and professional services market areas.

VERSAR operates the corporate web sites, www.versar.com, and www.versarpps.com, and www.jmwaller.com.

This news release contains forward-looking information.  The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements may be significantly impacted by certain risks and uncertainties described herein and in Versar’s Annual Report on Form 10-K filed with the Securities and Exchange Commission for the fiscal year ended June 27, 2014, as updated from time to time in the Company’s periodic filings. The forward-looking statements are made as of the date hereof and Versar does not undertake to update its forward-looking statements.

(ININ) to Host “Improve Patient Engagement and Profitability” Industry Web Event

Interactive Intelligence Group Inc. (Nasdaq: ININ), a global provider of software and services designed to improve the customer experience, is hosting a free Web event titled, “Improve Patient Engagement and Profitability: Embrace Consumerism and New Technology,” to be held Tuesday, Nov. 11, 2014 at 11:30 a.m. Eastern time (EST).

This 75-minute webcast is designed for customer service, contact center, and sales operations executives in the healthcare industry looking for strategies that address the growing trend of consumerism – a movement that’s requiring improved patient interactions in order to meet elevated service expectations.

This webcast will teach attendees how to use contact center and business process automation (BPA) technologies, along with industry best practices to cost-effectively improve patient interactions.

Webcast presenters will include Bill Ramalho, chief information officer/chief technology officer for Fairfax Family Practice Centers and Virginia Surgery Associates, who will share his experience deploying contact center and BPA solutions to improve profitability, outreach, and patient engagement.

Also presenting will be Nancy Jamison, principal analyst of information and communications technologies for Frost & Sullivan, who will share how key technologies can be used to address common challenges healthcare organizations face today as they work to improve patient relationships.

Webcast presenter Rachel Wentink, senior director of the business automation group for Interactive Intelligence, will share additional customer use cases showing how healthcare providers have integrated their contact center solutions with electronic health record (EHR) systems to deliver more personalized and cost-effective patient outreach.

An extensive Q&A will follow the presentations, during which Ramalho, Jamison, and Wentink will answer live audience questions.

To register for this Web event, visit: http://www.inin.com/WebEvent.

About Interactive Intelligence

Interactive Intelligence Group Inc. (Nasdaq: ININ) is a global provider of software and services designed to improve the customer experience. The company’s 6,000-plus customers worldwide have benefitted from its cloud and on-premises solutions for contact center, unified communications, and business process automation. Interactive Intelligence is among Software Magazine’s 2014 Top 500 Global Software and Service Providers, and has received a Frost & Sullivan Company of the Year Award for the last five consecutive years. In addition, Glassdoor honored Interactive Intelligence with its 2014 Employees’ Choice Award as one of the Best Places to Work in the U.S., and Mashable ranked Interactive Intelligence second on its 2014 list of the Seven Best Tech Companies to Work For. The company was founded in 1994 and employs more than 2,000 people worldwide. Interactive Intelligence is headquartered in Indianapolis, Indiana and has offices throughout North America, Latin America, Europe, Middle East, Africa and Asia Pacific. It can be reached at +1 317.872.3000 or info@inin.com. Visit Interactive Intelligence on the Web at www.inin.com; on Twitter at www.inin.com/twitter; on Facebook at www.inin.com/facebook; or on LinkedIn at www.inin.com/linkedin.

Interactive Intelligence is the owner of the marks INTERACTIVE INTELLIGENCE, its associated LOGO and numerous other marks. All other trademarks mentioned in this document are the property of their respective owners.

ININ-G

Interactive Intelligence
Christine Holley, Senior Director of Market Communications, +1 317-715-8220
christine.holley@inin.com

(OVRL) Strengthens Enterprise Scale-Out Solution

VMware-Certified SnapScale(R) Clustered Data Storage, Featuring RAINcloud(R) OS 4.1 Software, Protects and Manages Data in Cloud and Distributed Enterprise Environments

(JIVE) Announces Tony Zingale’s Retirement as CEO, New Role as Executive Chairman

Elisa Steele Promoted to President, and Appointed to ‘Office of CEO’ by Board of Directors Alongside Bill Lanfri, Independent Board Director

PALO ALTO, Calif., Nov. 4, 2014 — Jive Software, Inc. (Nasdaq:JIVE) today announced that Tony Zingale has decided to retire after almost five years as CEO. Zingale has served on Jive’s Board of Directors since 2007, was appointed CEO in 2010 and became Chairman in 2011. He will remain on the Board, and assume a new position as Executive Chairman focused primarily on strategic customer and partner relationships.

The company also announced the promotion of Elisa Steele, Executive Vice President of Marketing and Products, to President effective November 10, 2014. While a CEO search is underway, the Board has also appointed Steele to a newly created ‘Office of the CEO’ role effective November 10 – with responsibility for overseeing the day-to-day operations of the company until a new CEO is named – alongside independent board director Bill Lanfri, a member of Jive’s Board since 2008 with a 30-year leadership tenure in the enterprise networking and telecommunications markets.

Steele joined Jive in January 2014 as Chief Marketing Officer, with a subsequent promotion to Executive Vice President of Marketing and Products. Her background includes executive management roles at Microsoft, Skype, Yahoo! and NetApp.

“Jive’s market opportunity is big, and our time is now,” said Elisa Steele, President of Jive. “The industry has never been so ready for the enterprise collaboration solutions we provide. In close partnership with Jive’s world-class Board of Directors, I’m excited to help lead Jive to even greater success. I want to thank Tony for his leadership and guidance, and look forward to continuing our successful partnership in his new role.”

“I’m so proud of what we’ve achieved over the past five years, in which Jive has cemented its leadership position in the competitive and growing enterprise collaboration market,” said Zingale. “I especially want to thank our dedicated employees and customers around the world. I look forward to continuing on this journey with you, and helping to guide the company as Executive Chairman.”

“As a board member since 2007, I’ve seen Jive create the social business market and then continuously disrupt the industry with its market-leading innovations. Under Tony’s leadership, Jive has built the most comprehensive communication and collaboration platform in the market,” said Jim Goetz, Partner at Sequoia Capital and member of Jive’s Board. “I want to thank Tony for his leadership and for his many significant achievements as CEO – including taking the company public, acquiring a premier customer base and growing revenue 6x. I also want to congratulate Elisa on her well-deserved promotion to President and her exceptional contributions to Jive.”

This leadership transition is the result of a comprehensive management succession process led by the Board. The Board has retained Russell Reynolds Associates to conduct an executive search for Jive’s new CEO, and both internal and external candidates will be considered.

About Jive Software

Jive (Nasdaq:JIVE) is the leading provider of modern communication and collaboration solutions for business. Recognized as a leader by the industry’s top analyst firms in multiple categories, Jive enables employees, partners and customers to work better together. More information can be found at www.jivesoftware.com.

CONTACT: Investor Contact:
         Brian Denyeau
         ICR
         (646) 277-1251
         brian.denyeau@icrinc.com

         Media Contact:
         Jason Khoury
         Jive Software
         (650) 847-8308
         jason.khoury@jivesoftware.com

(ABAT) Announces Plans to Become Fully Reporting

Retains Paritz & Company, P.A. as Independent Auditor

(SCRI) Acquires Steel Media, Secures $25 Million in Financing

Combined Companies Enhance Real-Time Bidding Exchange and Expand Digital Advertising SSP and DSP Offerings

LOS ANGELES, Nov. 3, 2014 — Social Reality, Inc. (OTCBB: SCRI), a leader in automated digital platform technology and social management software for Internet advertising, announced today the acquisition of Steel Media, a privately held company with $10 million in expected 2014 revenues and a 14-year track record of providing display, mobile, video and email advertising inventory to top consumer brands and ad agencies.

Social Reality also announced $25 million in committed financing – a $20 million credit facility provided by Victory Park Capital, a Chicago-based asset management firm focused on middle market debt and equity investments, and $5 million of new equity financing provided by Siskey Capital, LLC and other existing investors.  Social Reality utilized a portion of the credit facility, together with the new equity in order to fund the acquisition of Steel Media, continue expansion of Social Reality’s SSP (supply-side platform) and DSP (demand side platform) offerings sold through its proprietary real-time bidding (RTB) exchange, and to provide a strong capital base for growth, working capital and general corporate purposes. Steel Media leadership has joined Social Reality as an integral part of the newly combined entity; Richard Steel has been named President, and Chad Holsinger will serve as Chief Revenue Officer of Social Reality. Social Reality’s CEO and Co-founder, Christopher Miglino, will continue to lead the company and will run the combined businesses.

“This strategic acquisition of Steel Media is an excellent fit for Social Reality, creating a powerful force in the digital advertising space. Together, our companies offer superior performance and technology for social data and Internet ad buy-and-sell solutions, delivered to agencies and brands by a seasoned and skilled digital sales team. The combined expertise of our two companies will further enhance the quality of our industry-leading technology and service, with faster delivery for our customers. We welcome the Steel Media team to Social Reality, and we look forward to executing on our combined strategic vision,” said Miglino. “We appreciate the tremendous support from Victory Park Capital as our new strategic financing partner, as well as that of our new and long-term financial partners, and we look forward to their contributions as we continue to grow our business. With the enhanced revenues and positive operating cash flow from this acquisition, combined with increased leverage and ability to reach into new markets, Social Reality is well-positioned for long-term growth.”

“Our team is excited to combine forces with Social Reality. Their SRAX technology platform is the go-to digital ad exchange in the industry. Expanding Steel Media’s product offerings for our customers will drive growth within the combined business,” said Steel. “We’re ready to make our mark, providing digital media solutions that are best-in-class, best-in-reach and best-in-speed. Our combined company now has strengths that span the complete digital spectrum.”

The company’s Social Reality Ad Exchange (SRAX) is an SSP that was launched in early 2013 in order to connect online publishers with demand partners and buyers through advanced programmatic technology and RTB integration. The SRAX platform has gained the reputation for making buying and selling of display, video, mobile and in-app advertising an easier and more efficient experience than other digital ad technologies. Its proprietary RTB management platform integrates social information to optimize client results from the DSP and SSP offerings. Social Reality’s GroupAd product offering is a complementary social management and tracking software focused on delivering brand advocacy and customer loyalty via an integrated dashboard, to launch, distribute and optimize social and digital media campaigns.

T.R. Winston & Company, LLC served as exclusive financial advisor to Social Reality in the acquisition of Steel Media, was sole lead arranger for the term loan financing, and served as agent for the equity financing. Social Reality’s legal advisors were Sidley Austin LLP and Pearlman Schneider LLP. Steel Media’s financial advisor for the transaction was Petsky Prunier Securities and its legal advisor was Lowenstein Sandler LLP. Victory Park Capital’s legal advisor was Katten Muchin Rosenman LLP.

About Social Reality

Founded in 2010, Los Angeles-based Social Reality, Inc. is an Internet advertising company that provides tools that automate the digital advertising market. The company has built technologies and leveraged partner technologies that service social media and the real-time bidding (RTB) markets. For more information, please visit www.socialreality.com www.srax.com  www.groupad.com

About Steel Media

Founded in 1999, Steel Media provides digital ad inventory to all top ten ad agencies, by billing, in the U.S., along with 30 of the Fortune 100 companies, all of whom rely on Steel Media for digital advertising needs. Steel Media provides display, mobile, video and email ad inventory to both brands and ad agencies. The company has technologies in place to dramatically optimize online display, mobile, email and video campaigns in order to increase the effectiveness of client’s ad spends. Steel Media provides brands and ad agencies the ability to deploy, manage, and measure all their digital advertising campaigns in one place. For more information, please visit www.steelmediainc.com.

About Victory Park Capital

Victory Park Capital (VPC) is a privately held registered investment advisor dedicated to alternative investing through the management of private investment funds.  As specialists in credit and private equity investments, VPC focuses on middle market companies across a diversified range of industries.  Whether as a lender or a control investor, VPC seeks to identify opportunities where it believes the potential for reward outweighs the risks entailed.  Founded in 2007, VPC is headquartered in Chicago with additional resources in Los Angeles, New York, San Francisco, Boston and London.

About Siskey Capital LLC

Siskey Capital LLC, is a private merchant bank based in Charlotte, North Carolina. The firm acts as financial partners in assisting emerging companies accomplish their near to long-term goals. Siskey Capital’s participation in any opportunity is primarily partnership driven, using its own capital, while providing extensive financial, structural, growth and risk management expertise. Its founders and principals are strong goal oriented experts that have over three decades of successful merchant banking, venture capital, international business and entrepreneurial backgrounds.

Forward-Looking Statements

This press release contains forward-looking statements. Any statements contained herein which do not describe historical facts, including but not limited to, statements regarding: (i) our business; (ii) the transaction with Steel Media, including expected benefits, opportunities, synergies, financing, results and the impact on revenue, adjusted operating earnings, EBITDA, shareholder value, and the impact on our financial profile; (iii) expectations about the combined company; (iv) SCRI’s intentions to provide further guidance and its intention to name the current Steel Media executives who will be joining SCRI’s leadership team; (v) expectations for the Steel Media commercial platform and our entry into a segment important for future growth; (vi) our belief that this is a transformative transaction that propels us into a profitable, multi-product company positioned for continued revenue, and operating income growth, further diversification and shareholder value creation; (vii) expectations regarding  future acquisitions; (viii) beliefs about the commercial platform and the strategic fit of Steel Media; (ix) our plans to expand our portfolio through the in-license or purchase of additional products or companies; and (x) our goal of bringing to the market services and products that provide clear benefits and improve our customers’ businesses, are forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those discussed in such forward-looking statements. Statements about SCRI’s or Steel Media’s past financial results do not, and are not meant to, predict future results. Social Reality can provide no assurance that such results and performance will continue.

Risks and uncertainties include, among others: (1) the possibility that we may not realize the expected benefits, synergies and opportunities anticipated in connection with the transaction, including the anticipated revenue and cost synergies, and continuing revenue growth, (2) the challenges of integrating the Steel Media commercial team with Social Reality, (3) the impact on sales from competitive pricing, and sales and marketing initiatives, (4) liabilities we assume from Steel Media that may be higher than expected, (5) the possibility that sales will not meet expectations as a result of current and future competition, (6) in connection with the Steel Media acquisition, we will incur a substantial amount of indebtedness and will have to comply with restrictive and affirmative debt covenants, (7) the expectation that we will need to raise additional capital from the sale of our common stock, which will cause significant dilution to our stockholders, in order to satisfy our contractual obligations, including our debt service, earn out payments that may become payable to Steel Media’s stockholder or in order to pursue business development activities, (8) due to the Steel Media transaction, we will be highly leveraged and have limited cash and cash equivalent resources which may limit our ability to take advantage of attractive business development opportunities and execute on our strategic plan, (9) our ability to execute on our long-term strategic plan or to realize the expected results from our long-term strategic plan, (10) our patents and proprietary rights both in the U.S. and outside the U.S. (including those that we acquire from the acquisition of Steel Media), (11) other risks identified in our filings with the U.S. Securities and Exchange Commission (SEC), including our Quarterly Report on Form 10-Q and subsequent filings with the SEC. Any of the above risks and uncertainties could materially and adversely affect our results of operations, our profitability and our cash flows, which would, in turn, have a significant and adverse impact on our stock price. Use of the term “including” in the two paragraphs above shall mean in each case “including, but not limited to.” We caution you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made.

We disclaim any obligation to publicly update or revise any such statements to reflect any change in expectations or in events, conditions or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements.

(RBCC) 3D Bioprinting Technology Developed by RBCC Partner n3D

A Texas Medical Center research team has made a stunning breakthrough in breast cancer research using revolutionary 3D bioprinting technology being marketed and developed by Nano3D Biosciences (n3D), a joint venture partner of Rainbow Coral Corp. (OTCBB:RBCC).

Researchers were able to create a better in vitro model of breast cancer by magnetically levitating cells using n3D’s Bio-Assembler, part of the world’s first commercially available 3D bioprinting system designed for high throughput and high-content drug screening. By magnetically levitating cell cultures, the research team was able to replicate in vitro the cell heterogeneity of the tumor microenvironment.

“These results signify a crucial breakthrough in studying cancer cells outside the body and developing new treatments. We at n3D are very proud that the Bio-Assembler, a technology we developed, is being used in critical research such as this important study,” said Dr. Glauco Souza, n3D president and chief science officer, and a co-author of the study, which was published in Scientific Reports, a top 5 multidisciplinary science primary research journal.

In the study, entitled “Three Dimensional In Vitro Co-Culture Model of Breast Tumor Using Magnetic Levitation,” research data suggests “that the proposed 3D in vitro breast tumor is advantageous due to the ability to: (1) form large-sized (millimeter in diameter) breast tumor models within 24 h; (2) control tumor cell composition and density; (3) accurately mimic the in vivo tumor microenvironment; and (4) test drug efficiency in an in vitro model that is comparable to in vivo tumors.”

For months, RBCC and n3D have been focused on raising millions of dollars to further market and develop 3D bioprinting technology around the globe.

“The Bio-Assembler uses biocompatible magnetic nanoparticles to levitate cells, allowing them to grow into 3D structures much faster, easier and more affordably than competing technology currently on the market,” said RBCC CEO Kimberly Palmer. “This cutting-edge study by the team in Texas perfectly shows why the Bio-Assembler is a technology coveted by leading scientists across a variety of disciplines and beautifully illustrates how it’s pushing cellular research forward.”

READ MORE ABOUT THE STUDY: http://www.nature.com/srep/2014/141001/srep06468/full/srep06468.html

VIEW FIGURES AND IMAGES: http://www.nature.com/srep/2014/141001/srep06468/fig_tab/srep06468_ft.html

About Rainbow Biosciences

Rainbow Biosciences, LLC, a wholly owned biotech subsidiary of Rainbow Coral Corp. (OTCBB:RBCC), was formed to deliver new medical and research technology innovations to a global marketplace in order to compete alongside companies such as Biogen Idec Inc. (NASDAQ:BIIB), Abbott Laboratories (NYSE:ABT) and Amgen Inc. (NASDAQ:AMGN). The Company continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. In 2012, Rainbow Biosciences acquired an equity interest in n3D. For more information on our growth-oriented business initiatives, please visit www.RainbowBioSciences.com. For investment information and performance data on the Company, please visit www.RainbowBioSciences.com/investors.html.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

(TWSI) Awarded Hemostasis and Compression Products Agreement With Premier

WESTPORT, Conn., Nov. 3, 2014  — HemCon Medical Technologies, Inc. (“HemCon”), a wholly owned subsidiary of TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced today that the company has been awarded a group purchasing agreement for Hemostasis and Compression Products with Premier, Inc. effective November 1, 2014. The new agreement (PP-CA-248) allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the entire line of HemCon hemostatic products, including products such as the HemCon Patch^® PRO, ideal for bleeding control following heart catheterizations, ChitoGauze^® PRO for traumatic injuries and GuardaCare^®XR Surgical, a must have tool for controlling bleeding and maintaining surgical field visibility in the operating room.

“HemCon is pleased to be included as a contracted supplier for Premier. Our company is committed to creating new healthcare products that drive improved patient safety and better clinical results across the continuum of care. We’re excited that Premier will make our proprietary hemostatic products available to their members and support them in their efforts of improving patient care,” said HemCon Chief Executive Officer and President, Michael Wax.

HemCon offers a comprehensive line of hemostatic products with a proven track record that quickly control all levels of bleeding. HemCon’s proprietary chitosan technology provides a cost-effective hemostatic solution to treat low to heavy arterial bleeding, while also providing antibacterial properties. HemCon’s ability to stop bleeding at all levels of the continuum of care allows hospitals to add efficiencies to their normal practices as well as greatly reducing everyday expenses, while improving patient outcomes.

About Premier, Inc.

Premier, Inc. is a leading healthcare improvement company, uniting an alliance of approximately 3,000 U.S. hospitals and 110,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost. Premier, a Malcolm Baldrige National Quality Award recipient, plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier’s news and investor sites on www.premierinc.com; as well as Twitter, Facebook, LinkedIn, YouTube, Instagram, Foursquare and Premier’s blog for more information about the company.

About HemCon Medical Technologies, Inc.

HemCon Medical Technologies Inc., is a wholly owned subsidiary of TriStar Wellness Solutions®, Inc. (OTCQB: TWSI). HemCon is a developer, manufacturer, and marketer of proprietary technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. HemCon was founded in 2001 and since then has been a supplier of medical devices to the military, emergency medical and law enforcement communities. This year the company received endorsement from the Tactical Combat Casualty Care (TCCC) and is an approved supplier of bandages and hemostatic devices to government agencies and allied militaries around the world.  The company this year also launched a sales force dedicated to serving the hospital and clinical markets. Additional information is available at www.hemcon.com.

About TriStar Wellness Solutions

TriStar Wellness Solutions®, Inc. (OTCQB: TWSI) is a health and wellness company that targets under-met opportunities in the OTC and professional marketplace. TriStar is the owner of HemCon Medical Technologies Inc., a company dedicated to saving lives through innovative wound care solutions.  It also owns the Beaute de Maman™ brand of women’s health products. Additional information is available at www.tstarwellness.com and www.beautedemaman.com.

Forward-Looking Statement

This press release for TriStar Wellness Solutions®, Inc. contains forward-looking statements. Generally, you can identify these statements because they use words like “anticipates,” “believes,” “expects,” “future,” “intends,” “plans,” and similar terms. These statements reflect only our current expectations. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy and actual results may differ materially from those we anticipated due to a number of uncertainties, many of which are unforeseen, including, among others, the risks we face as described our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements that apply only as of the date of this press release. To the extent that such statements are not recitations of historical fact, such statements constitute forward-looking statements that, by definition, involve risks and uncertainties. In any forward-looking statement where we express an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the statement of expectation of belief will be accomplished.

Website: http://www.tstarwellness.com

CONTACT:
Simona Buergi
Tel: (503) 245-0459
simona.buergi@hemcon.com

(IEGH) Corporation Chairman, Announces Record Mr. Amazing Loans

IEGH Breaks All Previous US Loan Volume Records With $1.05 Million of New Loans for Month of October

(MSPCD) Announces 500-to-1 Reverse Stock Split

MIAMI, FL, United States, via ETELIGIS INC., 11/03/2014 – – Metrospaces, Inc. (OTC Pink: MSPCD) (PINKSHEETS: MSPCD), announces the approval of a 500-to-1 reverse stock split.

Mr. Brito stated, Even though our company has evolved in just 2 years from a developer of small residential real estate projects to a mid-sized hotel developer, our stock price has not reflected it. Additionally, we have sold for a profit our first 2 projects; cash flow that is now being deployed for planning approval for the Tulasir Spa and Hotel and the Orinoco Oil Belt Business Hotel. However, due to our low stock price, it has been difficult to attract long term investors that will support our capital stock. We are very optimistic that this decision will help our company attract the sort of long term investors we know our company can. As we focus our resources on hotel development, we provide a US-based investment vehicle for investors looking for outsized returns by investing in emerging market hotel development deals. Additionally, we are certain to create additional shareholder value by creating one of the first boutique hotel chains in the region. With the JV hotel development agreement we executed with Prohotels (Argentina) we have put in place the right human resources to develop a world-class boutique hotel brand/concept. This agreement calls for the development of 4 hotels in the next 3 years, something we feel very optimistic to accomplish.

For a link to our 2 hotel projects currently underway:

https://db.tt/YYK50THw

https://db.tt/pE9Bsfnr

About Metrospaces

Metrospaces www.metrospaces.net is a publicly traded real estate investment and Development Company which acquires land, designs, builds, and develops then resells condominiums and Luxury High-End Hotels, principally in urban areas of Latin America. The companys current projects are located in Buenos Aires, Argentina, and Caracas, Venezuela.

Six years ago Metrospaces shareholders saw a unique opportunity to participate in several exciting property markets around the world. Through their world-wide network of highly recognized real estate entrepreneurs, the company was able to capitalize on unique real estate development opportunities. Since Inception the company has leveraged those relationships along with extensive financial expertise and transformed excellence by results.

Metrospaces is a boutique real estate development company, a product of the alliance of Metrospace shareholders, along with an elite group of real estate professionals and entrepreneurs located around the world. Company shareholders have extensive careers in real estate financing worldwide, and have funded projects both in the Americas and across Europe valued in excess of US $350Million.

Metrospaces majority shareholders has partnered with Investors on Elite properties including The London BLVGARI 5 Star Hotel, and is currently involved in negotiations for the development of several Elite luxury properties in South America.

Among Metrospace partners are Architects, Real Estate Developers, Agents and Attorneys of the highest standing, with extensive experience in the global property market.

Metrospaces was originally founded by company President Oscar Brito.

Relevant Links:

http://metrospaces.net/

Safe Harbor Statement:

Statements in this news release may be forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Metrospaces Inc. undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

CONTACT:

Metrospaces, Inc.

Tel: 305-600-0407

Investor Relations:

investors@metrospaces.net

(CAPR) to Hold Third Quarter 2014 Business Update Conference Call

LOS ANGELES, Oct. 31, 2014 — Capricor Therapeutics, Inc. (OTCBB:CAPR), a biotechnology company focused on developing novel therapeutics for the treatment of cardiovascular diseases, today announced that Company management will hold a conference call to discuss third quarter 2014 business highlights on Wednesday, November 12, 2014, at 4:30 p.m. ET.

On the call, Dr. Linda Marbán, Chief Executive Officer, will review Capricor’s recent accomplishments, provide an update on the clinical development program of the Company’s lead product candidate, CAP-1002, and discuss other Company updates.

Participants can register for the call and webcast via the following link: https://prismdigitalmedia.cwebcast.com/ses/5bIRxAY9rhdWBimYPQBW9A~~. Once registered for the call, interested parties will receive the conference call dial-in information. An archived version of the webcast will remain on the Company’s Investors page at http://www.capricor.com.

About Capricor Therapeutics

Capricor Therapeutics, Inc. (CAPR), a publicly traded biotechnology company, is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two leading product candidates: CAP-1002 and Cenderitide. The Company was formed through the November 2013 merger between Capricor, Inc., a privately held company whose mission is to improve the treatment of heart disease by commercializing cardiac stem cell therapies for patients, and Nile Therapeutics, Inc., a clinical-stage biopharmaceutical company developing innovative products for the treatment of cardiovascular diseases. For additional information visit www.capricor.com.

Cautionary Note Regarding Forward-Looking Statements

Statements in this press release regarding the efficacy, safety, and intended utilization of Capricor’s product candidates; the conduct, size, timing and results of discovery efforts and clinical trials; plans regarding regulatory filings, future research and clinical trials; plans regarding current and future collaborative activities and the ownership of commercial rights; future royalty streams, and any other statements about Capricor’s management team’s future expectations, beliefs, goals, plans or prospects constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words “believes,” “plans,” “could,” “anticipates,” “expects,” “estimates,” “should,” “target,” “will,” “would” and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements. More information about these and other risks that may impact our business are set forth in our Form 10-K for the year ended December 31, 2013, as filed with the Securities and Exchange Commission on March 31, 2014, in our Amendment No. 1 to Registration Statement on Form S-1, as filed with the Securities and Exchange Commission on May 23, 2014, and in our Form 10-Q for the quarter ended June 30, 2014, as filed with the Securities and Exchange Commission on August 14, 2014. All forward-looking statements in this press release are based on information available to us as of the date hereof, and we assume no obligation to update these forward-looking statements.

CONTACT: For more information, please contact:

         Capricor Therapeutics, Inc.
         AJ Bergmann, Vice President of Finance
         +1-310-358-3200
         abergmann@capricor.com

         ProActive Capital Group
         Kirin Smith, COO
         +1-646-863-6519
         ksmith@ProActiveCapital.com
         www.ProActiveCapital.com

(ARCW) CEO Featured Panelist at “Make it in America”

DELAND, Fla., Oct. 31, 2014  — ARC Group Worldwide, Inc. (NASDAQ: ARCW), a leading global provider of advanced manufacturing and 3D printing solutions, today announced that its CEO, Jason Young, will be a featured panelist at “Make it in America”, an event focused on the resurgence of U.S. manufacturing. Corridor Capital is hosting the event in Los Angeles on November 4, 2014. Mr. Young will be joining a panel of experts from the Milken Institute, McKinsey, Oaktree Capital and The National Association of Manufacturers to discuss the drivers of the new American manufacturing sector. For more information on the sold-out event, please visit www.make-it-in-america.org.

About ARC Group Worldwide, Inc.

ARC Group Worldwide is a leading global advanced manufacturing and 3D printing service provider.  Founded in 1987, the Company offers its customers a compelling portfolio of advanced manufacturing technologies and cutting-edge capabilities to improve the efficiency of traditional manufacturing processes and accelerate their time to market. In addition to being a world leader in metal injection molding (“MIM”), ARC has significant expertise in 3D printing and imaging, materials science, advanced tooling, automation, machining, stamping, plastic injection molding, lean manufacturing, and robotics. For more information about ARC Group Worldwide, please visit www.ArcGroupWorldwide.com, or its operating subsidiaries at www.3DMaterialTechnologies.com, www.AFTmim.com, www.AFTmimHU.com, www.ARCmim.com, www.ArcWireless.net, www.ATCmold.com, www.FloMet.com, www.GeneralFlange.com, www.Injectamax.com, www.kecycorporation.com, www.TeknaSeal.com, and www.ThixoWorks.com.

IMPORTANT INFORMATION

This press release may contain “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995, which are based on ARC’s current expectations, estimates and projections about future events. These include, but are not limited to, statements, if any, regarding business plans, pro-forma statements and financial projections, ARC’s ability to expand its services and realize growth. These statements are not historical facts or guarantees of future performance, events or results. Such statements involve potential risks and uncertainties, and the general effects of financial, economic, and regulatory conditions affecting our industries. Accordingly, actual results may differ materially. ARC does not have any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. For additional factors that may affect future results, please see filings made by ARC with the Securities and Exchange Commission (“SEC”), including its Form 10-K for the fiscal year ended June 30, 2013 and Form 10-Q for the period ended March 30, 2014, as well as current reports on Form 8-K filed from time-to-time with the SEC.

CONTACT: Drew M. Kelley

PHONE: (303) 467-5236

Email: InvestorRelations@ArcGroupWorldwide.com

(GCAP) to Acquire City Index and Announces Record Preliminary Third Quarter Results

– Transaction creates global leader in FX/CFD trading, with over 235,000 funded accounts, $1.2 billion in customer assets and $3.1 trillion in annual trading volume – – Transaction adds significant scale to GAIN’s retail business – – Results in estimated operating synergies of $45 million-$55 million within two years – – Preliminary third quarter 2014 results include record revenues of $103 million, up 69% – – Adjusted EBITDA* of $26.6 million, up 120%; 26% adjusted EBITDA Margin* – – Net income of $14.7 million, or $0.32 per share, up from $5.6 million or $0.14 per share – (*See below for reconciliation of non-GAAP financial measures)

BEDMINSTER, N.J., Oct. 31, 2014  — GAIN Capital Holdings, Inc. (NYSE: GCAP, “GAIN”), today announced that it has entered into a definitive agreement to acquire City Index (Holdings) Limited (“City Index”), a leading online trading firm specializing in contracts-for-difference (CFDs), forex and UK spread betting, for approximately $118 million¹, or a net purchase price of $82 million, including $36 million in cash on the company’s balance sheet.

The combination of GAIN Capital and City Index creates a global leader in online trading, operating two market-leading brands in GAIN’s FOREX.com, a top retail forex brand globally, and City Index, a premier CFD and spread bet brand. The combined company will service 235,000 retail customers in over 180 countries with annual trading volumes of more than $3 trillion.

“The acquisition of City Index advances our growth strategy, creating scale for our retail business and accelerates the development of our innovative trading technology,” said Glenn Stevens, GAIN’s chief executive officer. “The combination will result in a balanced mix of customer volume, with approximately 61% of retail volume coming from FX and 39% from CFD trading/UK spread betting in other asset classes such as equities, indices and commodities. We look forward to leveraging the City Index brand in key markets and working with the team at City Index, who share our commitment to creating a superior customer experience.”

“This transaction is a landmark moment in City Index’s 30-year history as a leader in retail trading,” said Mark Preston, City Index’s Chairman and Chief Executive. “The combination of GAIN’s unrivalled leadership in global foreign exchange with City Index’s internationally-recognized CFD business creates a world-class industry leader, providing the scale and capability to deliver the ultimate trading experience to our clients around the world. The combined business will also offer greater opportunities for City Index’s management and staff to flourish in a global business.”

Founded in London in 1983 as one of UK’s first spread betting companies, City Index is today one of the world’s leading providers of CFDs, forex and UK spread betting, offering more than 10,000 products across equity, index, FX, commodity and bond CFDs and spread bets. City Index is majority owned by IPGL, the private holding company for the interests of Michael Spencer, Founder and Chief Executive of ICAP plc, the global markets operator.

“I am very pleased we have been able to agree to this transaction, which brings benefits for everyone,” said Michael Spencer. “I believe GAIN is an outstanding company and will be able to move City Index to the next level, by leveraging its broad array of trading products and services onto a global platform. We believe this combination will enhance GAIN’s leadership position in the FX/CFD industry by putting together two highly complementary companies to create significant value for customers and stakeholders. This is the latest example of the way that IPGL is able to invest actively in businesses over the long term to support their growth and development.”

For the 12 month period ended September 30, 2014, City Index generated $124.8 million in revenue and $10.7 million in adjusted EBITDA. It had approximately 104,000 funded retail accounts and $344 million in customer assets as of September 30, 2014.

The combined company will have pro forma client assets of approximately $1.2 billion, and trailing twelve month revenues and adjusted EBITDA, for the period ended September 30, 2014, of $462 million and $61 million, respectively. GAIN has identified $45 million – $55 million of fixed operating expense synergies, relative to the combined company’s trailing twelve-month expenses, and expects to begin realizing theses synergies promptly after closing with full integration achieved over the ensuing 18-24 months. GAIN expects for this acquisition to become highly accretive over this time period and anticipates achieving accretive results by the fourth quarter following closing.

The transaction follows the successful acquisition and integration of GFT, which closed in September 2013, where GAIN Capital achieved approximately $40 million of run rate expense synergies.

City Index clients will not see any immediate impact to the customer service they receive, their account administration or how they trade. All clients will receive more detailed information about the benefits the combined company can offer them, once the acquisition is completed.

Terms of the Transaction

The purchase price will consist of $20 million in cash, $60 million of convertible notes and the issuance of approximately 5.3 million GAIN shares. The total purchase price of $118 million represents a $28 million premium above City Index’s book value as of September 30, 2014.

In addition to the $36 million of cash on its books as of September 30, 2014, City Index also has $65 million of net operating losses which can be carried forward following the closing of the transaction.

The transaction is subject to approval by GAIN Capital stockholders, regulatory approvals and customary closing conditions. The deal is expected to close in the first quarter of 2015.

Jefferies LLC is serving as exclusive financial advisor to GAIN Capital. Keefe, Bruyette & Woods, A Stifel Company is serving as financial advisor to IPGL. Davis Polk & Wardwell advised GAIN Capital on U.S. and UK legal matters.  Macfarlanes advised IPGL and City Index on UK legal matters and Kirkland & Ellis advised IPGL and City Index on U.S. legal matters.

City Index Acquisition Conference Call

GAIN will host a conference call today, Friday, October 31, 2014 at 8.00 a.m. ET.  Participants may access the live call by dialing + 1-866-652-5200 (U.S. domestic), or + 1-412-317-6060 (international).

A live audio webcast of the call and a copy of the accompanying presentation will also be available on the Investor Relations section of the GAIN website (http://ir.gaincapital.com). A PDF copy of the presentation will also be available on the Investor Relations website.

An audio replay will be made available for one month starting approximately two hours after the call by dialing + 1-877-344-7529 in the U.S. or + 1-412-317-0088 from abroad, and entering passcode 10055502#

Preliminary Third Quarter Results

GAIN Capital also announced today preliminary results for the third quarter ended September 30, 2014. Net revenues for the third quarter ended September 30, 2014 were a record $102.8 million, an increase of 69% from $60.8 million from a year earlier. Adjusted EBITDA for the period was $26.6 million, an increase of 120% from $12.1 million from a year earlier. Net income was $14.7 million, or $0.32 per diluted share, up 163% from $5.6 million, or $0.14 per diluted share a year earlier. Cash earnings per share, which reflect earnings per share less the impact of depreciation and amortization, purchased intangible amortization and non-cash interest was $0.40 per diluted share, an increase of 124% from a year earlier. The Company will review its full third quarter results on Thursday November 6, 2014 during a conference call scheduled for 8:00 a.m. Details for the conference call with be forthcoming.

About GAIN Capital

GAIN Capital Holdings, Inc. (NYSE: GCAP) provides innovative trading technology and execution services to retail and institutional investors worldwide, with multiple access points to OTC markets and global exchanges across a wide range of asset classes, including foreign exchange, commodities, and global equities. GAIN Capital is headquartered in Bedminster, New Jersey, with a global presence across North America, Europe and the Asia Pacific regions. For further company information, visit www.gaincapital.com

About City Index

City Index (Holdings) Ltd. is a global provider of retail trading services including spread betting (UK only), CFDs and margin forex. Established in 1983, the firm trades primarily under the City Index, Finspreads, FX Solutions and IFX Markets brands with core markets in the UK, Middle East and the Asia Pacific.
For further company information, visit www.cityindex.co.uk

(*) Reconciliation of Net Income to Cash Net Income and Cash EPS

Cash net income is a non-GAAP financial measure and represents our net income excluding depreciation and amortization, purchased intangible amortization and non-cash interest expense. This non-GAAP financial measure has certain limitations, including that it does not have a standardized meaning and, therefore, our definition may be different from similar non-GAAP financial measures used by other companies and/or analysts. Thus, it may be more difficult to compare our financial performance to that of other companies. We believe our reporting of cash net income assists investors in evaluating our operating performance. However, because cash net income is not a measure of financial performance calculated in accordance with GAAP, such measure should be considered in addition to, but not as a substitute for, other measures of our financial performance reported in accordance with GAAP, such as net income.

Reconciliation of GAAP Net Income to Adjusted EBITDA and Adjusted EBITDA Margin

Adjusted EBITDA is a non-GAAP financial measure that represents our earnings before interest, taxes, depreciation and amortization, restructuring, acquisition and integration-related expenses, impairment on investment and gain on extinguishment of debt. This non-GAAP financial measure has certain limitations, including that it does not have a standardized meaning and, therefore, our definition may be different from similar non-GAAP financial measures used by other companies and/or analysts. Thus, it may be more difficult to compare our financial performance to that of other companies. We believe our reporting of adjusted EBITDA assists investors in evaluating our operating performance. However, because adjusted EBITDA is not a measure of financial performance calculated in accordance with GAAP, such measure should be considered in addition to, but not as a substitute for, other measures of our financial performance reported in accordance with GAAP, such as net income.

Adjusted EBITDA Margin is adjusted EBITDA over net revenue.

Pro Forma Amounts

All pro forma amounts represent the combination of GAIN and City Index via simple addition.

Forward Looking Statements

The forward-looking statements contained herein include, without limitation, statements relating to GAIN Capital’s and/or City Index (Holdings) Limited (“City Index”) expectations regarding the opportunities and strengths of the combined company created by the proposed business combination, anticipated cost and revenue synergies, the strategic rationale for the proposed business combination, including expectations regarding product offerings, growth opportunities, value creation, and financial strength, and the timing of the closing.  All forward looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that GAIN Capital or City Index will realize these expectations or that these beliefs will prove correct. In addition, a variety of important factors could cause results to differ materially from such statements. These factors are noted throughout GAIN Capital’s annual report on Form 10-K, as filed with the Securities and Exchange Commission on March 17, 2014, and include, but are not limited to, the actions of both current and potential new competitors, fluctuations in market trading volumes, financial market volatility, evolving industry regulations, including changes in regulation of the futures companies, errors or malfunctions in GAIN Capital’s systems or technology, rapid changes in technology, effects of inflation, customer trading patterns, the success of our products and service offerings, our ability to continue to innovate and meet the demands of our customers for new or enhanced products, our ability to successfully integrate assets and companies we have acquired, our ability to effectively compete in the futures industry, changes in tax policy or accounting rules, fluctuations in foreign exchange rates and commodity prices, adverse changes or volatility in interest rates, as well as general economic, business, credit and financial market conditions, internationally or nationally, and our ability to continue paying a quarterly dividend in light of future financial performance and financing needs. The forward-looking statements included herein represent GAIN Capital’s views as of the date of this release. GAIN Capital undertakes no obligation to revise or update publicly any forward-looking statement for any reason unless required by law.

¹ The estimated total transaction value is based on the closing price of GAIN Capital common stock on October 30, 2014. The purchase price for accounting purposes will be determined upon the closing of the acquisition and will depend on GAIN Capital’s stock price at that time.

(ZYXI) Schedules Third Quarter 2014 Earnings Release and Webcast

(VTMB) Continues Double Digit Growth

(NSAV) Announces the Execution of a Due Diligence Evaluation

PORT JEFFERSON, NY, United States, via ETELIGIS INC., 10/31/2014 – – Net Savings Link, Inc. (OTC Pink: NSAV) (PINKSHEETS: NSAV) today has announced the execution of an agreement by our new President, Leonard F. Genovese, on behalf of NSAV, to conduct a formal due diligence evaluation for purposes of a targeted merger/acquisition with a well-established firm that has an entrenched and long term presence in the Artisanal food and beverage/wellness/ and retail distribution space in the Northeastern portion of the U.S., and is expanding nationally. Mr. Genovese commented; This is an exciting opportunity to pair the synergy of this firm with NSAV. The targeted firm has existing revenues with year over year growth for the past 3 fiscal terms, and has an established customer base that encompasses both a retail and institutional model. Mr. Genovese continued; The firm not only has a domestic presence, but also has a European base that brings significant product variety into existing domestic markets that we are optimistic to enter. They are a leader in imported foods from certain European markets, and they hold various proprietary food packaging agreements that will enhance product diversity. Mr. Genovese continued; we are optimistic that we will close on this agreement, pending the outcome of our D.D. evaluation, within the next 30-60 days.

Steven Baritz, the CEO of NSAV said, NSAV s recent decision to appoint Mr. Genovese has proven to already pay dividends in terms of corporate development, intermediate growth, and strategy. Mr. Genoveses mature contact base has expressed an eagerness to be a part of a firm that he is operating within a leadership capacity. Baritz continued, We are expressing extreme optimism that this will be the first of many strategic growth opportunities that Mr. Genovese will facilitate for NSAV, and we are certain that they will be well received by both the consumer as well as the shareholder and investor community. We will provide a subsequent update on the status of this announcement in a subsequent release upon the conclusion of the due diligence evaluation.

Mr. Baritz also commented on a recent concern of shareholders regarding the removal of the DTC chill; NSAV has made one of its top priorities, the removal of the DTC chill that has existed prior to the current management teams tenure on the Board. Baritz continued; It is apparent that in order for NSAV to move to the next level that will be commensurate with our intermediate and long term objectives, the removal of the chill will be of paramount importance, and we expect to commence the process to remove the chill as soon as certain self- imposed metrics are achieved in regard to capital availability and revenue expectations.

About Net Savings Link, Inc.:

Net Savings Link, Inc. owns and operates a wholly owned subsidiary, Global Distribution Corporation, a distribution company that markets and distributes products in varying industries including the supplement, wellness and natural remedies markets. People interested in learning more about Global Distribution should check back with the company at its website, www.Globaldistributioncorp.net.

DISCLAIMER: This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as “anticipates,” “believes,” “estimates,” “expects,” “plans,” “intends,” “potential” and similar expressions. These statements reflect the Company’s current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company’s actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information contained in this Press Release including such forward-looking statements.

CONTACT:

David Pecoraro

Shareholder Relations Director

Email: DavidPecoraro@rocketmail.com

Tel: 814-418-6648

(YEWB) Applauds China State Forestry Admin’s Subsidy Of Medicinal Herb Crops

HARBIN, China, Oct. 30, 2014  — Yew Bio-Pharm Group, Inc. (“Yew Bio” or the “Company”) (OTCBB: YEWB), a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine (TCM) and products made from yew timber, today applauded the creation of a subsidy program by the State Forestry Administration of China to promote the development and growth of Chinese medicinal herb crops.

The central China government continues to increase financial support to the national forest economy in efforts to promote the proportion of investment in other sectors of planting, and to help forestry and growers become a new economic growth point. Heilongjiang Provincial Forestry Department, where Yew Bio-Pharm is located, was recently selected to receive initial subsidies for undergrowth planting of Chinese medicine herbs.

Under Heilongjiang Province’s Forest Economic Development Plan, which was announced in January 2014, the forest economy in the province is expected to reach 150 billion yuan (approximately US$24.5 billion) by 2020. The plan focuses on developing Chinese medicine, forest mushrooms, berries, vegetables, seeds and other undergrowth corps.

“As a leading yew tree grower in the region, and producer of traditional Chinese medicine used in certain cancer treatments, we are very encouraged by this positive development,” said Mr. Zhiguo Wang, Chairman and Chief Executive Officer of Yew Bio-Pharm Group. “The subsidies should help spur development of new projects and incentivize economic growth in the region for growers of traditional Chinese medicine crops.”

“With our advanced planting technologies, and one of the largest yew forests in China with more than 20,000 MU (approximately 3,300 acres), we are optimistic about the possibility of receiving the national financial support. Through this funding, we can further utilize the company’s 1 million MU (approximately 165,000 acres) of forestland to plant globally scarce anti-cancer medicine herbs,” Wang added.

ABOUT YEW BIO-PHARM GROUP, INC.

Yew Bio-Pharm Group, Inc., through its operating entity, Harbin Yew Science and Technology Development Co., Ltd. (HDS), is a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine (TCM) and products made from yew timber in China. Raw material from the species of yew tree that the Company grows contains taxol, and TCM containing yew raw materials has been approved as a traditional Chinese medicine in China for secondary treatment of certain cancers. The Company uses a patented, accelerated growth technology to speed the growth and maturity and commercialization of yew trees and believes that it is one of the few companies possessing a permit to sell them. To learn more, please visit http://www.yewbiopharm.com/.

(SWRF) Provides an Update on the Completion of SoOum Merger

New York, NY / October 30, 2014 / Swordfish Financial, Inc. (OTC:SWRF) provides a shareholder update regarding the process of the pending Swordfish/SoOum merger.

SWRF is pleased to report the final steps of the forthcoming merger with SoOum Corp. SWRF has contracted a leading provider in investor communications and financial printing, to distribute the information statement (Schedule 14f-1) as officially required as part of completing the merger. The printing has been completed and the mailing in process. The certification that this information statement is being delivered to shareholders of record, along with a FINRA filing, and final forms to the US SEC, enables closing. SWRF has been advised that final merger can occur in approximately fourteen (14) days.

SoOum CEO, William Westbrook, reported that, “The motivation, morale and vision of the entire upper management in SoOum is healthy and increasing. The merger with Swordfish, which is nearing its completion, fulfills SoOum’s demand for new talent, specialized experience, technology and market reaches.”

Luis Vega, SoOum’s, Chief Operation and Trade Officer, reports they have seen a significant increase in new trade opportunities due to the publicity it has received from its merger announcement, http://www.sooum.com/.

Also of note, in development news, SoOum has been working with Trade Risk Group (www.traderiskgroup.com) in attaining credit insurance for its top importers, thereby enabling the Company to offer a broader range of payment terms to its leading customers and enhancing its capacity to grow with less risk.

For further information regarding this release, contact Rich Kaiser, Business Consultant, YES INTERNATIONAL, 757-306-6090 and/or yes@yesinternational.com.

This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 relating to matters such as prospects, anticipated operating and financial performance. Actual prospects and performance may differ from anticipated results due to economic conditions and other risks, uncertainties and circumstances partly or totally outside the control of the Company, including risks of market volatility, the level of capital expenditures required to fund ongoing trading operations and the ability of the Company to execute its business strategy. These and other risks are described in the Company’s reports filed with the United States Securities and Exchange Commission. These forward-looking statements are made only as of the date of this communication and the Company undertakes no obligation to update or revise these forward-looking statements.

Contact:
Rich Kaiser
757-306-6090
www.yesinternational.com

(OMER) Omidria™ Granted Pass-Through Reimbursement Status from CMS

— Unique Billing Code Allows Separate Payment for Omidria —

SEATTLE, Oct. 30, 2014  — Omeros Corporation (NASDAQ: OMER) announced today that it has received transitional pass-through status for its lead product Omidria^™ (phenylephrine and ketorolac injection) 1%/0.3% from the Center for Medicare & Medicaid Services (CMS), the federal agency that administers the Medicare program. Approved earlier this year by the U.S. Food and Drug Administration (FDA) for use during cataract surgery or intraocular lens replacement (ILR), Omidria is the only FDA-approved product for intraocular administration that prevents intraoperative miosis (pupil constriction) and reduces postoperative pain, providing consistent and predictable management of these problems for ophthalmic surgeons and their patients. A large and growing market, cataract and other ILR procedures are among the most common surgical procedures performed in the U.S. with approximately four million expected in 2015.

Transitional pass-through status will allow ambulatory surgery centers and other outpatient facilities to bill Medicare and other insurance providers for Omidria using a temporary Healthcare Common Procedure Coding System (HCPCS) code unique to Omidria. Pass‑through status allows for separate payment for new drugs and other medical technologies that meet specific clinical-value and cost requirements. Pass‑through remains in effect for a period of two to three years, after which time CMS and other insurance providers make a new reimbursement determination. Pass‑through status for Omidria will become effective on January 1, 2015, and reimbursement will be based on the product’s wholesale acquisition cost of between $400 and $500 per single-use vial.

“We are pleased with CMS’s decision to grant pass-through for Omidria,” said Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros. “Pass-through status should streamline the billing and reimbursement process for facilities that use Omidria and could accelerate adoption of the product across cataract and other intraocular lens procedures. Coincident with this new clarity on reimbursement, our commercial team is in the process of adding the second wave of sales representatives, and we plan to launch Omidria no later than early 2015.”

About Omidria^™
Omeros’ PharmacoSurgery^® product Omidria^™ (pronounced oh-MID-ree-uh) is a proprietary combination of the mydriatic (pupil-dilating) agent phenylephrine and the anti-inflammatory agent ketorolac, which was developed for use during cataract or other intraocular lens replacement (ILR) surgery. The FDA has approved Omidria (phenylephrine and ketorolac injection) 1%/0.3% for use during cataract surgery or ILR to maintain pupil size by preventing intraoperative miosis (pupil constriction) and to reduce postoperative pain. The European Medicines Agency (EMA) is currently reviewing the Marketing Authorization Application (MAA) for Omidria.

Important Risk Information for Omidria^™

Systemic exposure of phenylephrine may cause elevations in blood pressure. In clinical trials, the most common reported ocular adverse reactions at two to 24 percent are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation. Omidria^™ must be diluted prior to use. Omidria is not approved for use in children.

About Omeros Corporation

Omeros is a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. Derived from its proprietary PharmacoSurgery^® platform, the Company’s first drug product, Omidria^™ (phenylephrine and ketorolac injection) 1%/0.3%, has been approved by the FDA for use during cataract surgery or intraocular lens replacement (ILR) to maintain pupil size by preventing intraoperative miosis (pupil constriction) and to reduce postoperative ocular pain. Omeros is completing preparations for a planned U.S. product launch no later than early 2015. Omidria is currently under review for marketing approval by the European Medicines Agency. Omeros also has six clinical-stage development programs focused on complement-related thrombotic microangiopathies, Huntington’s disease, schizophrenia, and cognitive impairment; on addictive and compulsive disorders; and on preventing problems associated with surgical procedures. Omeros also has a proprietary GPCR platform, which is making available an unprecedented number of new GPCR drug targets and corresponding compounds to the pharmaceutical industry for drug development.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which are subject to the “safe harbor” created by those sections for such statements. All statements other than statements of historical fact are forward-looking statements, which are often indicated by terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “goal,” “intend,” “look forward to,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would” and similar expressions. Forward-looking statements are based on management’s beliefs and assumptions and on information available to management only as of the date of this press release. Omeros’ actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including, without limitation, risks associated with effectiveness of Omidria^™ sales and marketing efforts, Omidria market acceptance, product pricing and reimbursement, Omeros’ ability to obtain regulatory approval for its Marketing Authorization Application in the EU for the commercialization of Omidria, Omeros’ unproven preclinical and clinical development activities, regulatory oversight, product commercialization, intellectual property claims, competitive developments, litigation, and the risks, uncertainties and other factors described under the heading “Risk Factors” in the Company’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 11, 2014. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and the company assumes no obligation to update these forward-looking statements, even if new information becomes available in the future.

(SUIP) Licensing Agreement for BreastCare DTS™ With LMT

BreastCare DTS(TM) Is Patented, Non-Invasive, FDA-Cleared Cancer Detection Device; Agreement Gives Sunrise Exclusive Distribution Rights in US, Canada, China

(CAPA) acquires the assets of Movie Star News, LLC

LOS ANGELES, Oct. 30, 2014 — Capital Art, Inc., a publicly traded company (CAPA), has announced that it has acquired the assets of Movie Star News, LLC. The Movie Star News archive is believed to be one of the largest and most comprehensive collections of original Hollywood photography and contains more than 100,000 negatives and over 1 million original studio photos, including photos of Marilyn Monroe, Audrey Hepburn, Cary Grant and other iconic Hollywood legends. In addition, the assets consist of the Irving Klaw archive of over 9,000 original camera negatives featuring Bettie Page. Bettie Page is considered by many to be the first pin-up model in history.

Movie Star News began in 1938 when photographer Irving Klaw struck a deal with the movie studios, then operating in New York City, to collect movie photography that was in great demand by Hollywood fans.  Klaw eventually began to create an archive of Hollywood studio original negatives from which prints were made for the media and adoring fans. The collection was moved to Las Vegas, Nevada in August 2012, and when the iconic store on West 18^th Street closed, it was hailed as the closing of a New York institution by many national publications.

Irving Klaw is credited for creating the world of pin-up photography. He extensively photographed Bettie Page, who came to be known as the “Queen of Pin-Ups.” The Bettie Page Collection includes over 5,000 negatives, photographs, clothing and other invaluable props.

Capital Art, Inc. sells limited edition, fine art Hollywood prints featuring the Frank Worth Archive, the Movie Star News Archive and the Bettie Page Collection. The company also makes photographs available for publication rights through its agreement with Getty Images.

(CDTI) Unveils Breakthrough Clean Air Technology

Initial patents awarded for vehicle exhaust-cleaning technology – Eliminates need for expensive platinum group and rare earth metals

OXNARD, Calif., Oct. 30, 2014  — Clean Diesel Technologies, Inc. (Nasdaq:CDTI) (“CDTi” or “the Company”), a leader in advanced emission control technology, announced the United States Patent and Trademark Office (USPTO) awarded it two new patents covering CDTi’s new technology that replaces costly platinum group and rare earth metals in catalytic converters. These patents represent the first of a family of patents for CDTi’s Spinel™ technology, a proprietary clean emissions exhaust technology that promises to dramatically reduce the cost of attaining more stringent clean air standards.

The new technology will power multiple catalytic product lines that the Company believes have the potential to be highly disruptive to the traditional platinum-based or rare earth-based device industry. This is the Company’s first public announcement regarding its Spinel technology, the development of which has been kept confidential until now.

CEO Chris Harris commented, “Currently global OEMs spend billions of dollars annually on platinum group metals (PGMs) mined in South Africa and Russia, and hundreds of millions of dollars on Chinese-sourced rare earth metals. These costs are expected to dramatically increase with conventional technology as new regulations like U.S. EPA Tier 3 kick in. Spinel technology solves a major industry supply and cost problem and marks a major breakthrough both for us and for all OEMs around the world manufacturing fossil fuel-powered engines.”

About Spinel Technology

• A family of proprietary materials using various base metals that replace costly PGMs and rare earth metals in coatings on standard catalytic converters
• Works across a wide range of engine and vehicle applications – both gasoline and diesel
• Advanced testing underway on production models of popular passenger cars and heavy duty vehicles at respected independent vehicle test facilities

Spinel Technology Significance and Benefits

• Potential for significant cost savings for OEMs by cutting out expensive PGMs and rare earth metals
• Currently OEMs spend over $6 billion a year on PGMs (source: derived from Johnson Matthey PLC: Platinum 2013 Interim Review)
• Enables early, cost-effective compliance with stricter emissions standards in the U.S. and around the world
• Mitigates OEM exposure to supply uncertainty and price volatility in the PGM and rare earth markets

CTO Dr. Stephen Golden added, “The Spinel technology is the result of hard work and ingenuity by our world-class R&D team. It is an entirely new materials science pathway to meeting tighter regulations at much lower cost. Key validation vehicle testing is underway in parallel with aggressively building a broad IP portfolio as we incorporate Spinel technology into specific products for global OEMs.”

For more information on CDTi’s Spinel technology, please visit www.cdti.com/spinel.

About CDTi

CDTi is a vertically integrated global manufacturer and distributor of emission control systems and products, focused on the light duty vehicle and heavy duty diesel markets. CDTi utilizes its proprietary patented Mixed Phase Catalyst (MPC®) technology and other related technologies to provide high-value sustainable solutions to reduce emissions, increase energy efficiency and lower the carbon intensity of on- and off-road combustion engine systems. CDTi is headquartered in Oxnard, California and currently has operations in the U.S., the U.K., Canada, France, Japan and Sweden. For more information, please visit www.cdti.com.

About Platinum Groups Metals (PGMs)

Expensive PGM metals, which include platinum, palladium and rhodium, are used in the manufacture of emission control catalysts, with palladium and rhodium being the primary components used in catalysts serving the global light duty vehicle market. According to Johnson Matthey PLC’s “Platinum 2013 Interim Review,” in 2013, over 70% of all primary platinum and 80% of all primary rhodium produced originated in Southern Africa. Russia and Southern Africa combined supplied over 75% of palladium.

About Rare Earth Metals

Rare earth metals such as cerium, neodymium and lanthanum, also referred to as rare earth elements, are chemical elements used in many devices that people use every day, including computers, cell phones, rechargeable batteries and catalytic converters. As the global demand for these devices increases the use of rare earth metals is expected to rise. According to a 2014 U.S. Geological Survey Mineral Commodity Summary, the estimated value of refined rare earth metals imported by the U.S. in 2013 was $260 million. An estimated 79% of rare earth metals used in the U.S. were imported from China with 65% utilized in catalysts.

Forward-Looking Statements

Certain information contained in this press release constitutes forward-looking statements for purposes of the safe harbor provisions of The Private Securities Litigation Reform Act of 1995. Any statements contained herein that are not statements of historical fact should be considered forward-looking statements. You can identify these forward-looking statements by the use of the words “believes”, “expects”, “anticipates”, “plans”, “may”, “will”, “would”, “intends”, “estimates”, and other similar expressions, whether in the negative or affirmative. Forward-looking statements are based on a series of expectations, assumptions, estimates and projections which involve substantial uncertainty and risk. In this document, the Company includes forward looking statements regarding the anticipated or potential benefits of Spinel™ technology, anticipated increases in OEM expenditures on PGMs and rare earth metals with conventional technology, the effects of new regulations, additions to CDTi’s IP portfolio in parallel with continued vehicle testing, the incorporation of Spinel™ technology into products for OEMs, and the effects of Spinel™ technology on the traditional platinum-based or rare-earth based device industry and demand for platinum group and rare earth metals. In general, actual results may differ materially from those indicated by such forward-looking statements as a result of risks and uncertainties, including, but not limited, to (a) any inability by CDTi to (i) reduce costs; (ii) increase sales; (iii) realize benefits of investments; (iv) obtain sufficient funding; (v) realign its strategic path; (vi) execute its strategic priorities; (vii) commercialize its technology due to agreements with third parties; (viii) protect its intellectual property; (ix) obtain verifications, approvals or market acceptance of its products or technology; (x) attract or retain qualified personnel; (xi) achieve anticipated results; (b) changes in, lack of enforcement of or funding for emissions programs, regulations or standards; (c) competitive conditions; (d) fluctuations in or the stabilization of the prices of PGM and rare earth metals; (e) intellectual property infringement claims by third parties; (f) supply or delivery interruptions, limitations or failures; and (g) other risks and uncertainties discussed or referenced in the Company’s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K. In addition, any forward-looking statements represent the Company’s estimates only as of the date such statements are and should not be relied upon as representing the Company’s estimates as of any subsequent date. The Company specifically disclaims any obligation to update forward-looking statements. All forward-looking statements in this press release are qualified in their entirety by this cautionary statement.

CONTACT: Becky Herrick or Cathy Mattison
         LHA (IR Agency)
         +1 415 433 3777
         bherrick@lhai.com
         cmattison@lhai.com